Publications

Selected Publications 


Lenz G, Wright GW, Emre NC, Kohlhammer H, Dave SS, Davis RE, Carty S, Lam LT, Shaffer AL, Xiao W, Powell J, Rosenwald A, Ott G, Muller-Hermelink HK, Gascoyne RD, Connors JM, Campo E, Jaffe ES, Delabie J, Smeland EB, Rimsza LM, Fisher RI, Weisenburger DD, Chan WC, Staudt LM: Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways. Proc Natl Acad Sci U S A 105(36): 13520-5, 01/2008. PMID: 18765795

Gordon SM*, Carty SA*, Kim JS, Zou T, Smith-Garvin J, Alonzo ES, Haimm E, Sant'Angelo DB, Koretzky GA, Reiner SL, Jordan MS: Requirements for eomesodermin and promyelocytic leukemia zinc finger in the development of innate-like CD8+ T cells. J Immunol 186(8): 4573-8, 01/2011. PMID: 21383242 *co-first authors

Carty SA, Koretzky GA, Jordan MS: Interleukin-4 regulates eomesodermin in CD8+ T cell development and differentiation. PLoS One 9(9): e106659, 01/2014. PMID: 25207963

Prince AL, Kraus Z, Carty SA, Ng C, Yin CC, Jordan MS, Schwartzberg PL, Berg LJ: Development of innate CD4+ and CD8+ T cells in Itk-deficient mice is regulated by distinct pathways. J Immunol 193(2): 688-99, 01/2014. PMID: 24943215 

Carty SA, Gohil M, Banks LB, Cotton RM, Johnson ME, Stelekati E, Wells AD, Wherry EJ, Koretzky GA, Jordan MS. The Loss of TET2 Promotes CD8 T Cell Memory + Differentiation. J Immunol 200(1): 82-91, 01/2018. PMID: 29150566 

Fraietta JA, Nobles CL, Sammons MA, Lundh S, Carty SA, et al.: Disruption of TET2 promotes the therapeutic efficacy of CD19-targeted T cells. Nature 2018 Jun;558(7709):307-312 PMID: 29849141 

 

Comments